That’s incredible news!
I also understand that we can start immediate phase 2 trials for our other indications with ATL1102, is that right? (Predicated on our existing Pre clin/phase 1 safety data)
If so, would we need to do Phase 2, Phase 2B and Phase 3 trials for these other indications, or is it a shorter process?
That’s incredible news!I also understand that we can start...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.8¢ |
Change
0.001(1.30%) |
Mkt cap ! $70.32M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.0¢ | 7.7¢ | $36.71K | 467.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 114546 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 358002 | 2 |
View Market Depth
| Last trade - 10.39am 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.001 ( 1.30 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.0¢ | 7.8¢ | 45248 | ||
| Last updated 11.06am 07/05/2024 ? | |||||
| PER (ASX) Chart |